SBRI Healthcare Autumn 2014
The National Health Service England and the NHS Academic Health Science Networks have opened multiple new SBRI competitions with a total of £2.5m funding available in Phase 1 to develop technologies and innovative solutions that can provide better health outcomes in the areas of:
- Innovation in child & adolescent mental health
- Improving care of diabetic foot ulcer
- Medical imaging
- Improving efficiency & experience of outpatient services
- Brain injury healthcare
Phase 1 is intended to show the technical feasibility of the proposed concept. Development contracts will be awarded for a maximum of 6 months and £100,000 (inc VAT) per project. Projects that have completed Phase 1 successfully will be eligible for Phase 2 later in the year. Phase 2 contracts are intended to develop and evaluate prototypes or demonstration units from the more promising technologies in Phase 1.
More information including briefs for the challenges can be found on the website.
Application process
For further details, including the application process click here. The deadline for applications is 9 December 2014












Opportunities to support our REF preparations
SPROUT Returns: Designing Sustainability in Research Practice – Wednesday 20 May 12-2pm
Innovative Approaches to Doctoral Supervision: Selected Case Studies
3C Event: Research Culture, Community & Canapés-Tuesday 19 May 1-2pm
New chapters published in maternity book on risk
The British Academy European Research Council Grant Support Sessions
Apply now to take part in the 2026 ESRC Festival of Social Science
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease